We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ERNA icon
526
Eterna Therapeutics
ERNA
$4.56M
$4.56M $3.91 4.17%
LIMN
527
Liminatus Pharma
LIMN
$4.47M
$4.47M $3.33 5.13%
PMCB icon
528
PharmaCyte Biotech
PMCB
$4.47M
$4.47M $0.4162 8.87%
MLEC icon
529
Moolec Science
MLEC
$4.38M
$4.38M $6.03 9.05%
ADXN
530
Addex Therapeutics
ADXN
$4.25M
$4.25M $3.36 3.07%
GRI
531
GRI Bio
GRI
$3.96M
$3.96M $1.81 0.55%
NIKI
532
Niki BioSolutions
NIKI
$3.88M
$3.88M $4.77 5.92%
JUNS
533
Jupiter Neurosciences
JUNS
$3.86M
$3.86M $2.93 2.66%
ELAB icon
534
Elevai Labs
ELAB
$3.86M
$3.86M $4.77 1.04%
CVKD icon
535
Cadrenal Therapeutics
CVKD
$3.85M
$3.85M $1.08 2.86%
MBIO icon
536
Mustang Bio
MBIO
$3.79M
$3.79M $0.5000 0.7%
HCWB icon
537
HCW Biologics
HCWB
$3.69M
$3.69M $2.01 1.95%
GOVX icon
538
GeoVax Labs
GOVX
$3.68M
$3.68M $0.4052 3.18%
REVB icon
539
Revelation Biosciences
REVB
$3.66M
$3.66M $0.9200 1.05%
EOCN
540
Eocene Ltd. Ordinary Shares
EOCN
$3.64M
$3.64M $3.41 6.06%
BRTX icon
541
BioRestorative Therapies
BRTX
$3.52M
$3.52M $2.55 3.41%
VIVS
542
VivoSim Labs
VIVS
$3.51M
$3.51M $0.2621 3.82%
TCRT icon
543
Alaunos Therapeutics
TCRT
$3.25M
$3.25M $1.28 9.22%
SXTP icon
544
60 Degrees Pharmaceuticals
SXTP
$3.25M
$3.25M $0.9240 9.17%
XRTX
545
XORTX Therapeutics
XRTX
$3.23M
$3.23M $1.78 5.32%
APVO icon
546
Aptevo Therapeutics
APVO
$3.11M
$3.11M $1.72 0.58%
SILO icon
547
Silo Pharma
SILO
$3.09M
$3.09M $1.76 9.28%
ONCO icon
548
Onconetix
ONCO
$2.91M
$2.91M $0.6634 2.82%
GNPX icon
549
Genprex
GNPX
$2.8M
$2.8M $3.41 3.02%
SPRC icon
550
SciSparc
SPRC
$2.72M
$2.72M $4.68 1.68%
19 20 21
22
23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.